News

Since the COVID-19 pandemic began, Cigna has taken important steps to provide meaningful value for clients, provide easier access to care, and ease the financial impact to customers for COVID-19 testing and treatment.

As federal guidelines evolve with the COVID-19 pandemic, Cigna is adopting a position consistent with an anticipated extension of the federal public health emergency period. As such, we extended the customer cost-share waivers and other enhanced benefits through October 31.

Extending to October 31, 2020*:

• Cost share waiver for COVID-19 diagnostic testing, related visit and treatment
• Cost share waiver for COVID-19 related virtual medical visits
• Providing hospitals the flexibility to schedule elective procedures with prior authorization that may have been delayed due to hospital capacity challenges

As employers look to plan reopening worksites, it’s an important reminder to understand tests are covered when prescribed by a medical professional for an individual either showing symptoms of COVID-19 or who has been exposed to COVID-19. Non-diagnostic and antibody tests are not covered by Cigna’s standard coverage. For more testing, please download the Cigna testing brochure on the Cigna.com/pathback Returning to the Worksite web page.

Cigna’s extension helps deliver peace of mind for those we serve, and underscores Cigna’s commitment to delivering access to affordable, predictable and simple health care during this unprecedented time.

Helping our clients and customers stay healthy and safe, we also created the Coronavirus Resource page (Cigna.com/Coronavirus), which includes helpful tools, insights into available solutions, and tips about effective preventive measures such as the importance of wearing a mask and social distancing.